Aarhus University Seal / Aarhus Universitets segl

NAD+ in Aging: Molecular Mechanisms and Translational Implications

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Evandro F. Fang, Høgskolen i Oslo og Akershus
  • ,
  • Sofie Lautrup
  • ,
  • Yujun Hou, National Institute on Aging
  • ,
  • Tyler G. Demarest, National Institute on Aging
  • ,
  • Deborah L. Croteau, National Institute on Aging
  • ,
  • Mark P. Mattson, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore
  • ,
  • Vilhelm A. Bohr, National Institute on Aging, Københavns Universitet

The coenzyme NAD+ is critical in cellular bioenergetics and adaptive stress responses. Its depletion has emerged as a fundamental feature of aging that may predispose to a wide range of chronic diseases. Maintenance of NAD+ levels is important for cells with high energy demands and for proficient neuronal function. NAD+ depletion is detected in major neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, cardiovascular disease and muscle atrophy. Emerging evidence suggests that NAD+ decrements occur in various tissues during aging, and that physiological and pharmacological interventions bolstering cellular NAD+ levels might retard aspects of aging and forestall some age-related diseases. Here, we discuss aspects of NAD+ biosynthesis, together with putative mechanisms of NAD+ action against aging, including recent preclinical and clinical trials. Recent discoveries have demonstrated an age-dependent decrease in cellular and/or tissue NAD+ levels in laboratory animal models. Moreover, NAD+ depletion has been linked to multiple hallmarks of aging.In premature aging animal models, NAD+ levels are decreased, while NAD+ replenishment can improve lifespan and healthspan through DNA repair and mitochondrial maintenance.Mitochondrial autophagy (mitophagy) has a major role in clearance of damaged and/or dysfunctional mitochondria, and compromised mitophagy has been linked to metabolic disorders, neurodegeneration [including Alzheimer's disease (AD) and Parkinson's disease (PD)] in addition to aging, and other age-related diseases.New evidence suggests that NAD+ precursors, such as nicotinamide and nicotinamide riboside, forestall pathology and cognitive decline in mouse models of AD.NAD+ supplementation can inhibit multiple aging features in animal models. This highlights essential roles for NAD+ in maintaining healthy aging, and suggests that NAD+ repletion may have broad benefits in humans.

OriginalsprogEngelsk
TidsskriftTrends in Molecular Medicine
Vol/bind23
Nummer10
Sider (fra-til)899-916
Antal sider18
ISSN1471-4914
DOI
StatusUdgivet - okt. 2017

Se relationer på Aarhus Universitet Citationsformater

ID: 117816035